2nd Quarter - Report

EMD SERONO, INC. for EMD SERONO INC

Firm
Client
Income
—
Expenses
$640,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

12 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

H.R. 3: Elijah E. Cummings Lower Drug Costs Now Act; all provisions of the bill H.R. 19: Lower Costs, More Cures Act of 2021; all provisions of the bill H.R. 1957: Veterans Infertility Treatment Act of 2021; all provisions of the bill H.R. 4390: Preserving Rules Ordered for The Entities Covered Through (PROTECT) 340B Act of 2021; all provisions of the bill H.R. 5030: Diversifying Investigations Via Equitable Research Studies for Everyone (DIVERSE) Trials Act; all provisions of the bill H.R. 5376: Build Back Better Act; all provisions of the bill H.R. 6000: Cures 2.0 Act; all healthcare provisions of the bill H.R. 6584: Diverse and Equitable Participation in Clinical Trials (DEPICT) Act; all provisions of the bill H.R. 6963: Accelerated Approval Integrity Act of 2022; all provisions of the bill H.R. 6996: Accelerating Access for Patients Act of 2022; all provisions of the bill H.R. 7667: Food and Drug Amendments of 2022; provisions related to drug development user fees S. 2210: Better Care Better Jobs Act; all provisions of the bill S. 2706: Diversifying Investigations Via Equitable Research Studies for Everyone (DIVERSE) Trials Act; all provisions of the bill S. 4348: Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act of 2022; provisions related to drug development user fees 2021 Notice of Benefit and Payment Parameters Proposed Rule - 340B Drug Pricing Program policy issues General discussions regarding support for, and importance of, care-giving General healthcare issues surrounding the COVID-19 pandemic General issues surrounding healthcare supply chain General discussions regarding drug cost and pricing policy issues General discussions regarding The American Jobs Plan General discussions related to the Cancer Moonshot Initiative and the Advanced Research Projects Agency for Health (ARPA-H) General discussion related to the Prescription Drug User Fee Act Reauthorization

LobbyistCovered position, as disclosed
THOMAS BORCK New Senate Budget Committee (Chairman Mike Enzi) - Policy Director (5/18 - 11/19) Professional Staff Member (7/15 - 5/18); Representative Todd Rokita - Deputy Chief of Staff & Legislative Director (4/13 - 7/15) Legislative Assistant (10/11 - 4/13)
MALLORI ANNE MERANDINO —
TERRI STEWART —

Contacted: White House Office; SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 6000 (117th), H.R. 5376 (117th), H.R. 6584 (117th), H.R. 5030 (117th), H.R. 19 (117th), S. 2706 (117th), H.R. 7667 (117th), S. 2210 (117th), H.R. 4390 (117th), H.R. 6996 (117th), H.R. 6963 (117th), S. 4348 (117th), H.R. 1957 (117th), H.R. 3 (117th)

Medicare/Medicaid MMM

H.R. 3: Elijah E. Cummings Lower Drug Costs Now Act; all provisions of the bill H.R. 5376 - Build Back Better Act; all provisions of the bill 2021 Notice of Benefit and Payment Parameters Proposed Rule - 340B Drug Pricing Program policy issues General healthcare issues surrounding the COVID-19 pandemic

LobbyistCovered position, as disclosed
THOMAS BORCK New Senate Budget Committee (Chairman Mike Enzi) - Policy Director (5/18 - 11/19) Professional Staff Member (7/15 - 5/18); Representative Todd Rokita - Deputy Chief of Staff & Legislative Director (4/13 - 7/15) Legislative Assistant (10/11 - 4/13)
MALLORI ANNE MERANDINO —
TERRI STEWART —

Contacted: Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 3 (117th), H.R. 5376 (117th)

Pharmacy PHA

H.R. 3: Elijah E. Cummings Lower Drug Costs Now Act; all provisions of the bill H.R. 4390: Preserving Rules Ordered for The Entities Covered Through (PROTECT) 340B Act of 2021; all provisions of the bill H.R. 5376: Build Back Better Act; all provisions of the bill 2021 Notice of Benefit and Payment Parameters Proposed Rule - 340B Drug Pricing Program policy issues General healthcare issues surrounding the COVID-19 pandemic General issues surrounding healthcare supply chain General issues related to pharmaceutical pricing General issues related to drug development lifecycle

LobbyistCovered position, as disclosed
THOMAS BORCK New Senate Budget Committee (Chairman Mike Enzi) - Policy Director (5/18 - 11/19) Professional Staff Member (7/15 - 5/18); Representative Todd Rokita - Deputy Chief of Staff & Legislative Director (4/13 - 7/15) Legislative Assistant (10/11 - 4/13)
MALLORI ANNE MERANDINO —
TERRI STEWART —

Contacted: Centers For Medicare and Medicaid Services (CMS); SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Bills named: H.R. 5376 (117th), H.R. 4390 (117th), H.R. 3 (117th)

Budget/Appropriations BUD

General discussion related to President Biden's FY 2022 Proposed Budget

LobbyistCovered position, as disclosed
THOMAS BORCK New Senate Budget Committee (Chairman Mike Enzi) - Policy Director (5/18 - 11/19) Professional Staff Member (7/15 - 5/18); Representative Todd Rokita - Deputy Chief of Staff & Legislative Director (4/13 - 7/15) Legislative Assistant (10/11 - 4/13)
MALLORI ANNE MERANDINO —
TERRI STEWART —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Taxation/Internal Revenue Code TAX

General discussions related to the Budget Reconciliation bills and Section 163(n) issues related to inbound taxation (Global Intangible Low-Taxed Income (GILTI); Foreign-derived Intangible Income (FDII); Base-Erosion and Anti-Abuse Tax (BEAT), and the Stopping Harmful Inversions and Ending Low-Tax Developments (SHIELD) Rule)

LobbyistCovered position, as disclosed
STEPHANIE FRYE (FORMERLY SALVAGNO) —
PAUL JEFFREY TREADGOLD —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Science/Technology SCI

H.R. 4521: United States Innovation and Competition Act of 2021; provisions related to the inclusion of the CHIPS Act & FABS Act and issues related to the outbound investment review mechanism (National Critical Capabilities Act) S. 1260: United States Innovation and Competition Act of 2021 (USICA): provisions related to the inclusion of the CHIPS Act & FABS Act and issues related to the outbound investment review mechanism (National Critical Capabilities Act) Bipartisan Innovation Act; provisions related to the inclusion of the CHIPS Act & FABS Act and issues related to the outbound investment review mechanism (National Critical Capabilities Act)

LobbyistCovered position, as disclosed
STEPHANIE FRYE (FORMERLY SALVAGNO) —
PAUL JEFFREY TREADGOLD —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 1260 (117th), H.R. 4521 (117th)

Economics/Economic Development ECN

General discussion of issues related to caregiving and the Healthy Women, Healthy Economies initiative

LobbyistCovered position, as disclosed
MALLORI ANNE MERANDINO —

Contacted: Executive Office of the President (EOP); SENATE; HOUSE OF REPRESENTATIVES

Family issues/Abortion/Adoption FAM

H.R.1957: Veterans Infertility Treatment Act of 2021; all provisions of the bill

LobbyistCovered position, as disclosed
MALLORI ANNE MERANDINO —

Contacted: HOUSE OF REPRESENTATIVES

Bills named: H.R. 1957 (117th)

Veterans VET

H.R. 8238: Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2023; provisions related to funding infertility services at Veterans Affairs General discussions related to infertility treatment of the Veteran community

LobbyistCovered position, as disclosed
MALLORI ANNE MERANDINO —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 8238 (117th)

Copyright/Patent/Trademark CPT

General issues related to domestic and global intellectual property protections

LobbyistCovered position, as disclosed
THOMAS BORCK New Senate Budget Committee (Chairman Mike Enzi) - Policy Director (5/18 - 11/19) Professional Staff Member (7/15 - 5/18); Representative Todd Rokita - Deputy Chief of Staff & Legislative Director (4/13 - 7/15) Legislative Assistant (10/11 - 4/13)
MALLORI ANNE MERANDINO —
TERRI STEWART —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Trade (domestic/foreign) TRD

General discussions related to Section 301 tariffs and support for tariff exclusion process

LobbyistCovered position, as disclosed
STEPHANIE FRYE (FORMERLY SALVAGNO) —
PAUL JEFFREY TREADGOLD —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Chemicals/Chemical Industry CHM

General discussions related to the Toxic Substance Control Act (TSCA) Implementation Review Process of the New and Existing Chemicals programs

LobbyistCovered position, as disclosed
STEPHANIE FRYE (FORMERLY SALVAGNO) —
PAUL JEFFREY TREADGOLD —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.